280 related articles for article (PubMed ID: 31985052)
21. Intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial.
Tanen DA; Miller S; French T; Riffenburgh RH
Ann Emerg Med; 2003 Jun; 41(6):847-53. PubMed ID: 12764341
[TBL] [Abstract][Full Text] [Related]
22. Continuous Intravenous Valproate as Abortive Therapy for Pediatric Status Migrainosus.
Zafar MS; Stewart AM; Toupin DN; Cook AM; Baumann RJ
Neurologist; 2018 Mar; 23(2):43-46. PubMed ID: 29494433
[TBL] [Abstract][Full Text] [Related]
23. Sodium valproate prophylaxis in childhood migraine.
Serdaroglu G; Erhan E; Tekgul H; Oksel F; Erermis S; Uyar M; Tutuncuoglu S
Headache; 2002 Sep; 42(8):819-22. PubMed ID: 12390647
[TBL] [Abstract][Full Text] [Related]
24. Intravenous ibuprofen versus sodium valproate in acute migraine attacks in the emergency department: A randomized clinical trial.
Dogruyol S; Gur STA; Akbas I; Kocak MB; Kocak AO; Ceylan M; Tekyol D
Am J Emerg Med; 2022 May; 55():126-132. PubMed ID: 35313227
[TBL] [Abstract][Full Text] [Related]
25. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report.
Mathew NT; Kailasam J; Meadors L; Chernyschev O; Gentry P
Headache; 2000 Oct; 40(9):720-3. PubMed ID: 11091289
[TBL] [Abstract][Full Text] [Related]
26. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.
Apostol G; Lewis DW; Laforet GA; Robieson WZ; Fugate JM; Abi-Saab WM; Saltarelli MD
Headache; 2009 Jan; 49(1):45-53. PubMed ID: 19040679
[TBL] [Abstract][Full Text] [Related]
27. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
Krymchantowski AV; Jevoux CC
Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
[TBL] [Abstract][Full Text] [Related]
28. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
Cady RK; Saper J; Dexter K; Cady RJ; Manley HR
Headache; 2015 Apr; 55(4):529-42. PubMed ID: 25828648
[TBL] [Abstract][Full Text] [Related]
29. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial.
Khani S; Hejazi SA; Yaghoubi M; Sharifipour E
J Headache Pain; 2021 Apr; 22(1):21. PubMed ID: 33827421
[TBL] [Abstract][Full Text] [Related]
31. Intravenous sodium valproate for acute migraine in the emergency department: A meta-analysis.
Wang F; Zhang H; Wang L; Cao Y; He Q
Acta Neurol Scand; 2020 Dec; 142(6):521-530. PubMed ID: 32740903
[TBL] [Abstract][Full Text] [Related]
32. Use of intravenous valproate sodium in status migraine.
Norton J
Headache; 2000 Oct; 40(9):755-7. PubMed ID: 11091297
[TBL] [Abstract][Full Text] [Related]
33. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate.
Mathew NT; Kailasam J; Meadors L
Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644
[TBL] [Abstract][Full Text] [Related]
34. Intravenous Sodium Valproate for Acute Pediatric Headache.
Sheridan D; Sun B; O'Brien P; Hansen M
J Emerg Med; 2015 Oct; 49(4):541-5. PubMed ID: 25986331
[TBL] [Abstract][Full Text] [Related]
35. Probable valproate sodium-associated hypotension.
Ota KS
Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
[TBL] [Abstract][Full Text] [Related]
36. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
37. Enhancing Outpatient Dihydroergotamine Infusion With Interdisciplinary Care to Treat Refractory Pediatric Migraine: Preliminary Outcomes From the Comprehensive Aggressive Migraine Protocol ("CAMP").
Connelly M; Sekhon S; Stephens D; Boorigie M; Bickel J
Headache; 2020 Jan; 60(1):101-109. PubMed ID: 31626335
[TBL] [Abstract][Full Text] [Related]
38. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
[TBL] [Abstract][Full Text] [Related]
39. Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States.
Starling AJ; Kymes S; Asher D; Soni-Brahmbhatt S; Karnik-Henry M
BMC Neurol; 2023 Apr; 23(1):158. PubMed ID: 37081405
[TBL] [Abstract][Full Text] [Related]
40. Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review.
Zorrilla N; Gelfand AA; Irwin SL
Headache; 2023 Jan; 63(1):177-182. PubMed ID: 36633118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
